Written Notification to University. Adaptimmune informing Universal and University in writing, pursuant to Article 11.4 “Notices”, that it wishes to enter into such direct license with University, within the Initial Notice Period;
Appears in 3 contracts
Sources: Research Collaboration and License Agreement (Adaptimmune Therapeutics PLC), Research Collaboration and License Agreement (Adaptimmune Therapeutics PLC), Non Exclusive Sub License Agreement (Adaptimmune Therapeutics PLC)